Injectable medication might help specific populations reach heart disease prevention targets

Madely Health Headlines Commentary for March 27, 2012

 

 

Source:

New Injection Might Lower Tough-to-Treat Cholesterol

Reference:

Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy

Bitnami